DNMT3A and chronic myelogenous leukemia, BCR-ABL1 positive: In the case of DNMT3A, the dominant part of mutations come from various hematopoietic cancers, such as acute myeloid leukemia (AML), chronic myeloid leukemia (CML) or lymphoma.